home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News sources

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
By nameBy acronym
  A   B   C   D
  E   F   G   H
  I   J   K   L
  M   N   O   P
  Q   R   S   T
  U   V   W   X
  Y   Z   
Archives
News archive 1997-2008
 
Yield10 Bioscience

June 17, 2019


Yield10 Bioscience files U.S. patent application covering new technology enabling low-cost production of PHA-based biomaterials in camelina


May 10, 2019


Yield10 Bioscience announces first quarter 2019 financial results


May 8, 2019


Yield10 Bioscience signs exclusive worldwide license with University of Missouri for advanced technology used to boost oil content in crops


April 23, 2019


Yield10 Bioscience announces Notice of Allowance for U.S. patent covering crop yield trait C3003


April 4, 2019


Why now is the time for the convergence of agriculture and CRISPR technology (AgDaily)


March 25, 2019


Yield10 Bioscience announces fourth quarter and full year 2018 financial results


March 15, 2019


Yield10 Bioscience announces pricing of $2.9 million registered direct offering


February 28, 2019


An easier way to engineer plants - ​MIT-led team uses nanoparticles to deliver genes into plant chloroplasts


February 26, 2019


Yield10 Bioscience is developing gene-edited corn for increased yields (The Spoon)


January 22, 2019


Yield10 Bioscience initiates early development program in corn to evaluate novel traits


January 15, 2019


Yield10 Bioscience reports encouraging results from 2018 field tests of C3003 and announces advancement of C3003 into commercial development for canola


December 17, 2018


Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor


November 9, 2018


Yield10 Bioscience announces third quarter 2018 financial results


October 2, 2018


Yield10 Bioscience obtains nonregulated status for its novel CRISPR-Cas9 triple gene edited camelina plant lines to boost seed oil content


September 18, 2018


Editing in a yield increase - Yield10 is an ag bioscience company focused on targeted genes that show promise in boosting yield (Wallaces Farmer)


September 5, 2018


Yield10 Bioscience reports promising seed yield results for novel yield trait C3004 in growth chamber studies in camelina - Fast-tracking deployment of C3004 trait into canola and soybean


August 10, 2018


Yield10 Bioscience announces second quarter 2018 financial results


August 8, 2018


Yield10 Bioscience signs research license agreement covering CRISPR-Cas9 genome-editing technology with the Broad Institute and Corteva Agriscience


July 11, 2018


Yield10 Bioscience names Dr. Jay J. Thelen, Ph.D. to Scientific Advisory Board


July 2, 2018


Yield10 Bioscience begins field testing of novel yield trait gene C3003 and novel trait gene C3008 in oilseed crops


June 21, 2018


Yield10 Bioscience researchers publish research in Plant Cell Reports describing the development of its camelina platform as a model crop for novel yield trait discovery


May 10, 2018


Yield10 Bioscience announces first quarter 2018 financial results


May 9, 2018


Yield10 Bioscience researchers publish research in Plant Science showing that novel transcription factors represent a promising approach for increasing crop productivity


March 9, 2018


With a free pass, CRISPR-edited plants reach market in record time (Yield10 Bioscience)


Yield10 Bioscience announces fourth quarter and full year 2017 financial results


December 21, 2017


Yield10 Bioscience announces closing of $14.5 million public offering


December 11, 2017


Yield10 Bioscience grants research license to Monsanto to evaluate two novel yield traits in soybean


September 7, 2017


Yield10 Bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited camelina line





Previous

http://www.yield10bio.com


Copyright @ 1992-2025 SeedQuest - All rights reserved